These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15032193)
1. Genetics and drugs. FDA Consum; 2004; 38(1):7. PubMed ID: 15032193 [No Abstract] [Full Text] [Related]
2. When to conduct a renal impairment study during drug development: US Food and Drug Administration perspective. Huang SM; Temple R; Xiao S; Zhang L; Lesko LJ Clin Pharmacol Ther; 2009 Nov; 86(5):475-9. PubMed ID: 19844224 [TBL] [Abstract][Full Text] [Related]
3. "Getting the dose right": facts, a blueprint, and encouragements. Peck CC; Cross JT Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068 [No Abstract] [Full Text] [Related]
4. Genomics and personalized medicine. Meadows M FDA Consum; 2005; 39(6):12-7. PubMed ID: 16669113 [No Abstract] [Full Text] [Related]
5. Pharmacogenomics. Going from genome to pill. Service RF Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283 [No Abstract] [Full Text] [Related]
6. New recommendations to modernize drug manufacturing. FDA Consum; 2007; 41(1):4. PubMed ID: 17354283 [No Abstract] [Full Text] [Related]
10. A stepwise approach to evaluating new drug therapy. Wessell A; Blair M JAAPA; 2001 Nov; 14(11):10-1. PubMed ID: 11766421 [No Abstract] [Full Text] [Related]
11. The coming pharmacogenomics revolution: tailoring drugs to fit patients' genetic profiles. Noah L Jurimetrics; 2002; 43(1):1-28. PubMed ID: 17333591 [TBL] [Abstract][Full Text] [Related]
12. General considerations for studies of the metabolism of drugs and other chemicals. Glocklin VC Drug Metab Rev; 1982; 13(6):929-39. PubMed ID: 6754317 [No Abstract] [Full Text] [Related]
14. Pushing drugs: genomics and genetics, the pharmaceutical industry, and the law of negligence. Feldman HL Washburn Law J; 2003; 42(3):575-99. PubMed ID: 15115000 [No Abstract] [Full Text] [Related]
15. Meeting the demands of regulatory requirements: the significance of ADME. Guttendorf R Bioanalysis; 2012 Jun; 4(12):1395-7. PubMed ID: 22793021 [No Abstract] [Full Text] [Related]
17. Pharmacokinetic drug interaction studies must consider pharmacological heterogeneity, use of repeated dosing, and translation into a message understandable to practicing clinicians. de Leon J; Spina E; Diaz FJ J Clin Psychopharmacol; 2009 Jun; 29(3):201-5. PubMed ID: 19440070 [No Abstract] [Full Text] [Related]
18. Drug shortages: an increasing problem for patients and clinicians. Johnson TJ S D Med; 2011 Jan; 64(1):14-5. PubMed ID: 21337920 [No Abstract] [Full Text] [Related]
19. [Definition of phases for research on drugs in man]. Rahn KH Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1618-9. PubMed ID: 4592632 [No Abstract] [Full Text] [Related]
20. In brief: Non-inferiority trials. Med Lett Drugs Ther; 2011 Jan; 53(1355):1. PubMed ID: 21212743 [No Abstract] [Full Text] [Related] [Next] [New Search]